Search Results - "BOCHIS, OVIDIU VASILE"
-
1
Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis
Published in PloS one (28-04-2021)“…Colorectal cancer remains one of the most frequent malignancies (third place at both genders) worldwide in the last decade, owing to significant changes in…”
Get full text
Journal Article -
2
PLATINUM HYPERSENSITIVITY REACTIONS, A FOCUS ON DESENSITISATION
Published in Farmacia (București) (28-06-2021)Get full text
Journal Article -
3
Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer-the Experience of a Tertiary Cancer Center
Published in Frontiers in pharmacology (11-03-2021)“…Colorectal cancer (CRC) is the third most common cancer in Europe, with an annual increase in incidence ranging between 0.4 and 3.6% in various countries…”
Get full text
Journal Article -
4
Combined effect of propranolol, vincristine and bevacizumab on HUVECs and BJ cells
Published in Experimental and therapeutic medicine (01-01-2019)“…Infantile hemangioma is one of the most common benign tumors affecting children, with ~10-15% requiring medical treatment. These tumors consist of endothelial…”
Get full text
Journal Article -
5
Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report
Published in Gynecologic oncology reports (01-02-2021)“…•Paraneoplastic cerebellar degeneration may precede the diagnosis of cancer.•Early diagnosis of paraneoplastic cerebellar degeneration improve the…”
Get full text
Journal Article -
6
Treatment beyond progression in metastatic colorectal cancer: to double or not to double the dose of bevacizumab?
Published in Journal of B.U.ON. : official journal of the Balkan Union of Oncology (01-03-2020)“…Bevacizumab or cetuximab represent the standard treatment in association with classical chemotherapy in confirmed metastatic colorectal cancer (mCRC)…”
Get more information
Journal Article -
7
What to do when nothing else is left to be done - metastatic non-HPV vulvar squamous cell carcinoma with multiple lines of chemotherapy
Published in Archive of clinical cases (01-01-2021)“…Recurrent vulvar squamous cell carcinoma with multiple site metastases is a rare entity - (up to 14.2% of the total number of recurrences), with a poor…”
Get full text
Journal Article -
8
Decrease of oncological patients’ hospital visits during Covid-19 pandemic: The experience of a tertiary Romanian center
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e13607 Background: The outbreak of COVID-19 pandemic has changed the provision of medical services worldwide. Oncological patients continued…”
Get full text
Journal Article -
9
A breakthrough in treatment of cancer patients with grade 4/profound febrile neutropenia
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e14513 Background: febrile neutropenia (FN) remains one of the most serious side effects of chemotherapy treatment, which is life-threatening…”
Get full text
Journal Article -
10
Solid pseudopapillary tumor of the pancreas: clinical-pathological features and management of 13 cases
Published in Clujul medical (2017)Get full text
Journal Article -
11
The Importance of Ubiquitin E3 Ligases, SCF and APC/C, in Human Cancers
Published in Clujul medical (2015)“…A normal evolution of the cell-cycle phases consists of multiple consecutive events, which makes it a highly complex process. Its preservation is regulated by…”
Get full text
Journal Article -
12
The importance of a multidisciplinary team in rectal cancer management
Published in Clujul medical (2017)Get full text
Journal Article -
13
-
14